Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 38

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 38
---
 the originally diagnosed cancer, which is referred to as a second primary cancer. An                
 early warning system could help to identify a recurrence as early as possible, thereby helping to accelerate any treatment and diagnosis. 
 The different types of recurrence include:                                                                                                |

| o | Local recurrence, meaning                                        
 that the cancer has returned in the same place it first started; |

| o | Regional recurrence,                                                                         
 meaning that the cancer has returned to the lymph nodes near the place it first started; and |

| o | Distant recurrence,                                          
 meaning the cancer has returned in another part of the body. |

| ● | Response to treatment.                                                                                                               
 At Renovaro Cube we aim to develop a new array of diagnostic products that can accurately identify patients that are going to        
 respond or fail to a certain drug. In highly toxic therapies it will not only increase survival, but it will also reduce unnecessary 
 exposure to chemotherapy. Furthermore, the costs for cancer drugs are usually very high. Providing the right therapy to the right    
 patient will therefore significantly reduce the costs of medicine in cancer.                                                         |

| ● | Clinical trials.                                                                                                                          
 Clinical trials involve a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.    
 People volunteer to take part in clinical trials to test medical interventions including drugs, cells and other biological products,      
 surgical procedures, radiological procedures, devices, behavioral treatments and preventive care. Clinical trials are carefully designed, 
 reviewed and completed, and need to be approved before they can start.                                                                    |

Corporate Information

We are incorporated under the
laws of Delaware. Our principal executive offices are located at 2080 Century Park East, Suite 906, Los Angeles, California 90067. Our
telephone number is (305) 918-1980. Our website address is www.renovarogroup.com. The references to our website in this prospectus
are inactive textual references only. The information on our website is neither incorporated by reference into this prospectus nor intended
to be used in connection with this offering. We have included our website address in this prospectus as an inactive textual reference
only and not as an active hyperlink.

<div align='center'>4

RISK FACTORS</div>

Investing in our securities involves
risks. You should carefully consider the risks, uncertainties and other factors described in our most recent Annual Report on Form 10-K
and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and in other